H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 81 Citations 21,805 198 World Ranking 609 National Ranking 28

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Antigen

Günter J. Hämmerling mostly deals with Immunology, Antigen, Major histocompatibility complex, Molecular biology and MHC class I. His Immunology course of study focuses on Cancer research and Immunotherapy. His research in Antigen tackles topics such as Spleen which are related to areas like Interferon gamma.

His Major histocompatibility complex study frequently links to related topics such as Cytotoxic T cell. The concepts of his Molecular biology study are interwoven with issues in Cell culture, Antibody, Monoclonal antibody, Immunoperoxidase and Cell type. The various areas that he examines in his MHC class I study include Antigen presentation and Cell biology.

His most cited work include:

  • Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. (516 citations)
  • Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter (498 citations)
  • T Cell Awareness of Paternal Alloantigens During Pregnancy (485 citations)

What are the main themes of his work throughout his whole career to date?

Immunology, Antigen, Molecular biology, Major histocompatibility complex and Cell biology are his primary areas of study. The study of Immunology is intertwined with the study of Cytotoxic T cell in a number of ways. The study incorporates disciplines such as Receptor and T-cell receptor in addition to Antigen.

His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Gene, Transfection and Antibody, Monoclonal antibody. Günter J. Hämmerling works on Major histocompatibility complex which deals in particular with MHC class I. His work deals with themes such as Antigen presentation and Peptide, which intersect with MHC class I.

He most often published in these fields:

  • Immunology (38.05%)
  • Antigen (34.59%)
  • Molecular biology (31.13%)

What were the highlights of his more recent work (between 2010-2019)?

  • Immunology (38.05%)
  • Cell biology (22.01%)
  • Immune system (16.04%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Immunology, Cell biology, Immune system, Cytotoxic T cell and FOXP3. His study in T cell, CD8, Antigen, Innate immune system and Tumor microenvironment is carried out as part of his studies in Immunology. His biological study focuses on Major histocompatibility complex.

The concepts of his Cell biology study are interwoven with issues in Cell, Tetraspanin and Antigen-presenting cell. His work deals with themes such as Proinflammatory cytokine and Spleen, which intersect with Immune system. The Cytotoxic T cell study combines topics in areas such as Infiltration and Immune tolerance.

Between 2010 and 2019, his most popular works were:

  • Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. (516 citations)
  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) (345 citations)
  • Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis (242 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

Günter J. Hämmerling mainly investigates Immunology, FOXP3, CD8, Antigen and Cellular differentiation. His work in Immunology covers topics such as Transplantation which are related to areas like MHC class I and Syngeneic Bone Marrow Transplantation. His CD8 study incorporates themes from Infiltration, Pathology, Melanoma and Neovascularization.

His Cellular differentiation study combines topics in areas such as Carcinogenesis, Cancer, Tumor microenvironment, Cancer immunotherapy and Cytotoxic T cell. His study looks at the relationship between Major histocompatibility complex and fields such as T-cell receptor, as well as how they intersect with chemical problems. His Antigen-presenting cell research focuses on Antigen presentation and how it connects with Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

T Cell Awareness of Paternal Alloantigens During Pregnancy

Anna Tafuri;Judith Alferink;Peter Möller;Günter J. Hämmerling.
Science (1995)

751 Citations

Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction

Günther Schönrich;Ulrich Kalinke;Frank Momburg;Marie Malissen.
Cell (1991)

711 Citations

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

Birgit Liliensiek;Birgit Liliensiek;Markus A. Weigand;Angelika Bierhaus;Werner Nicklas.
Journal of Clinical Investigation (2004)

680 Citations

Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter

Jacques J. Neefjes;Frank Momburg;Gunter J. Hammerling.
Science (1993)

670 Citations

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

Felix Klug;Hridayesh Prakash;Hridayesh Prakash;Hridayesh Prakash;Peter E. Huber;Tobias Seibel.
Cancer Cell (2013)

639 Citations

Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

R. Wallich;N. Bulbuc;G. J. Hämmerling;S. Katzav.
Nature (1985)

541 Citations

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

Juliana Hamzah;Manfred Jugold;Fabian Kiessling;Paul Rigby.
Nature (2008)

517 Citations

Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues.

Frank Momburg;Frank Momburg;Gerhard Moldenhauer;Günter J. Hämmerling;Peter Möller.
Cancer Research (1987)

454 Citations

Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein

Dorothea Rudolph;Anna Tafuri;Peter Gass;Günter J. Hämmerling.
Proceedings of the National Academy of Sciences of the United States of America (1998)

428 Citations

Selectivity of MHC-encoded peptide transporters from human, mouse and rat

Frank Momburg;Joost Roelse;Jonathan C. Howard;Geoffrey W. Butcher.
Nature (1994)

399 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Günter J. Hämmerling

Robert Tampé

Robert Tampé

Goethe University Frankfurt

Publications: 69

Jacques Neefjes

Jacques Neefjes

Leiden University Medical Center

Publications: 62

Percy A. Knolle

Percy A. Knolle

Technical University of Munich

Publications: 55

Peter Cresswell

Peter Cresswell

Yale University

Publications: 52

Chella S. David

Chella S. David

Mayo Clinic

Publications: 48

Hidde L. Ploegh

Hidde L. Ploegh

Boston Children's Hospital

Publications: 46

Tim Elliott

Tim Elliott

University of Southampton

Publications: 44

Frank Momburg

Frank Momburg

German Cancer Research Center

Publications: 44

Rick M. Maizels

Rick M. Maizels

University of Glasgow

Publications: 34

Bernd Arnold

Bernd Arnold

German Cancer Research Center

Publications: 34

Elizabeth D. Mellins

Elizabeth D. Mellins

Stanford University

Publications: 34

Christian Kurts

Christian Kurts

University of Bonn

Publications: 30

Angelika Bierhaus

Angelika Bierhaus

Heidelberg University

Publications: 28

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 28

Federico Garrido

Federico Garrido

University of Granada

Publications: 27

Peter van Endert

Peter van Endert

Inserm : Institut national de la santé et de la recherche médicale

Publications: 27

Something went wrong. Please try again later.